Avecho Biotechnology Limited

Research Avecho Biotechnology Limited (AVE.AX) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025AUD 1.25M-AUD 4.42MAUD 1.10M71.9%0AUD 4.66MAUD 14.47KAUD 1.56M
FY2024AUD 1.29M-AUD 3.12M-AUD 3.97M64.4%0AUD 2.37MAUD 1.08MAUD 3.27M
FY2023AUD 473.55K-AUD 3.44M-AUD 3.18M-9.2%0AUD 5.52MAUD 175.15KAUD 6.38M
FY2022AUD 1.21M-AUD 2.34M-AUD 1.72M72.1%0AUD 1.55MAUD 246.08KAUD 2.45M

About Avecho Biotechnology Limited

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations.

Related stock research

Other Healthcare stocks

Frequently asked questions

What does Avecho Biotechnology Limited do?

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches.